The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms

Eitemau Tebyg

• The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions
  gan: Bhullar, Jasjeet, et al.
  Cyhoeddwyd: (2013)
• The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the multidrug resistance-associated ATP-binding cassette transporter ABCG2
  gan: Sen, Rupashree, et al.
  Cyhoeddwyd: (2012)
• Large-scale purification of functional human P-glycoprotein (ABCB1)
  gan: Nandigama, Krishnamachary, et al.
  Cyhoeddwyd: (2019)
• Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions
  gan: Shukla, Suneet, et al.
  Cyhoeddwyd: (2017)
• Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2
  gan: Shukla, Suneet, et al.
  Cyhoeddwyd: (2009)